Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-03

FDA Approved: ZALEPLON — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

FDA approved a supplemental application for Zaleplon from Unichem Pharmaceuticals (USA), Inc., under the existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zaleplon (Zaleplon)

Snippet

SUPPL AP for ZALEPLON (ZALEPLON)